GIB Capital, acting as financial advisor to Arabian Company for Pharmaceutical and Medical Appliances ("ACDIMA"), announces the successful completion of a share sale transaction in Saudi Pharmaceutical Industries and Medical Appliances Corporation ("SPIMACO").

ACDIMA sold 11,998,000 shares, representing approximately 9.998% of SPIMACO's capital, to Capital Investment Fund 44 and Capital Investment Fund 49, for total proceeds of SAR 326.35 million, at a price of SAR 27.20 per share. The transaction was executed through negotiated deals on the Saudi Exchange (Tadawul) on 21 July 2026.

Following completion of the transaction, ACDIMA now holds approximately 10.5% of SPIMACO’s capital.

GIB Capital has been providing a range of innovative and customized financial and investment banking products and solutions, including debt capital markets, capital markets advisory, mergers and acquisitions, debt advisory, asset management, and brokerage services.